SOLIAN

This brand name is authorized in Australia, Austria, Croatia, Cyprus, Estonia, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Mexico, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug SOLIAN contains one active pharmaceutical ingredient (API):

1
UNII 8110R61I4U - AMISULPRIDE
 

Amisulpride is a neuroleptic. Amisulpride binds selectively with a high affinity to human dopaminergic D2/D3 receptor subtypes whereas it is devoid of affinity for D1, D4 and D5 receptor subtypes.

 
Read more about Amisulpride

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 SOLIAN Tablets MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N05AL05 Amisulpride N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AL Benzamides
Discover more medicines within N05AL05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 8594H, 8595J, 8596K, 8736T
DE Bundesinstitut für Arzneimittel und Medizinprodukte 00018431, 01827397, 01827434, 01827440, 02246917, 06136433, 08425012, 08425029
EE Ravimiamet 1012105, 1041141, 1067497
ES Centro de información online de medicamentos de la AEMPS 5267, 63994, 63995, 63996, 65991
FR Base de données publique des médicaments 60019927, 62921036, 63697872, 64726693, 65637856
GB Medicines & Healthcare Products Regulatory Agency 143684, 143691, 143697, 19246, 19247, 19250, 28422, 39342
HK Department of Health Drug Office 46025, 47779, 47780
HR Agencija za lijekove i medicinske proizvode HR-H-345193647
IE Health Products Regulatory Authority 46655, 46708, 46724, 46857, 46870, 62895, 62897
IL מִשְׂרַד הַבְּרִיאוּת 4588, 4589
IT Agenzia del Farmaco 033462021, 033462045
LT Valstybinė vaistų kontrolės tarnyba 1003162, 1003618, 1012368, 1067873, 1087921
MX Comisión Federal para la Protección contra Riesgos Sanitarios 580M2000
PL Rejestru Produktów Leczniczych 100098237, 100098243, 100098266, 100375010, 100450297, 100458238, 100461179
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W64419001, W64420001
SG Health Sciences Authority 09773P, 11463P, 11464P
TN Direction de la Pharmacie et du Médicament 6483104, 6483105
TR İlaç ve Tıbbi Cihaz Kurumu 8699809018563, 8699809018570, 8699809097759, 8699809097766, 8699809655065
ZA Health Products Regulatory Authority 34/2.6.5/0116, 34/2.6.5/0117

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.